Putting p53 in context

ER Kastenhuber, SW Lowe - Cell, 2017 - cell.com
TP53 is the most frequently mutated gene in human cancer. Functionally, p53 is activated by
a host of stress stimuli and, in turn, governs an exquisitely complex anti-proliferative …

[HTML][HTML] Hyperpolarized 13C MRI: path to clinical translation in oncology

J Kurhanewicz, DB Vigneron, JH Ardenkjaer-Larsen… - Neoplasia, 2019 - Elsevier
This white paper discusses prospects for advancing hyperpolarization technology to better
understand cancer metabolism, identify current obstacles to HP (hyperpolarized) 13 C …

[HTML][HTML] Comprehensive genomic profiles of small cell lung cancer

J George, JS Lim, SJ Jang, Y Cun, L Ozretić, G Kong… - Nature, 2015 - nature.com
We have sequenced the genomes of 110 small cell lung cancers (SCLC), one of the
deadliest human cancers. In nearly all the tumours analysed we found bi-allelic inactivation …

Targeting autophagy in obesity: from pathophysiology to management

Y Zhang, JR Sowers, J Ren - Nature Reviews Endocrinology, 2018 - nature.com
Obesity poses a severe threat to human health, including the increased prevalence of
hypertension, insulin resistance, diabetes mellitus, cancer, inflammation, sleep apnoea and …

Compendium of human transcription factor effector domains

LF Soto, Z Li, CS Santoso, A Berenson, I Ho, VX Shen… - Molecular cell, 2022 - cell.com
Transcription factors (TFs) regulate gene expression by binding to DNA sequences and
modulating transcriptional activity through their effector domains. Despite the central role of …

Type 2 diabetes as a protein misfolding disease

A Mukherjee, D Morales-Scheihing, PC Butler… - Trends in molecular …, 2015 - cell.com
Type 2 diabetes (T2D) is a highly prevalent and chronic metabolic disorder. Recent
evidence suggests that formation of toxic aggregates of the islet amyloid polypeptide (IAPP) …

Targeting glucose metabolism enzymes in cancer treatment: current and emerging strategies

Y Zhang, Q Li, Z Huang, B Li, EC Nice, C Huang, L Wei… - Cancers, 2022 - mdpi.com
Simple Summary Reprogramming of glucose metabolism is a hallmark of cancer and can be
targeted by therapeutic agents. Some metabolism regulators, such as ivosidenib and …

The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains

AA Alekseyenko, EM Walsh, X Wang… - Genes & …, 2015 - genesdev.cshlp.org
NUT midline carcinoma (NMC), a subtype of squamous cell cancer, is one of the most
aggressive human solid malignancies known. NMC is driven by the creation of a …

Protein-level mutant p53 reporters identify druggable rare precancerous clones in noncancerous tissues

P Yao, P Xiao, Z Huang, M Tang, X Tang, G Yang… - Nature Cancer, 2023 - nature.com
Detecting and targeting precancerous cells in noncancerous tissues is a major challenge for
cancer prevention. Massive stabilization of mutant p53 (mutp53) proteins is a cancer-specific …

Emerging roles of p53 family members in glucose metabolism

Y Itahana, K Itahana - International journal of molecular sciences, 2018 - mdpi.com
Glucose is the key source for most organisms to provide energy, as well as the key source
for metabolites to generate building blocks in cells. The deregulation of glucose …